BeiGene, Ltd. Website

BeiGene, Ltd.

NasdaqGS-BGNE

Basic

  • Market Cap

    $17.28B

  • EV

    $15.62B

  • Shares Out

    105.81M

  • Revenue

    $2,762.63M

  • Employees

    10,000

Margins

  • Gross

    84.69%

  • EBITDA

    -36.55%

  • Operating

    -39.77%

  • Pre-Tax

    -26.51%

  • Net

    -28.39%

  • FCF

    -54.12%

Returns (5Yr Avg)

  • ROA

    -30.41%

  • ROTA

    -43.73%

  • ROE

    -43.42%

  • ROCE

    -37.44%

  • ROIC

    -148.45%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $264.27

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $2,793.37M

  • Net Debt

    -$1,730.26M

  • Debt/Equity

    0.32

  • EBIT/Interest

    -343.97

Growth (CAGR)

  • Rev 3Yr

    47.4%

  • Rev 5Yr

    62.54%

  • Rev 10Yr

    71.53%

  • Dil EPS 3Yr

    -17.69%

  • Dil EPS 5Yr

    -10.15%

  • Dil EPS 10Yr

    23.01%

  • Rev Fwd 2Yr

    27.92%

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    -38.66%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

428.2

308.9

1,176.3

1,415.9

2,458.8

2,762.6

Total Revenues % Chg.

116%

-27.9%

280.8%

20.4%

73.7%

77.4%

Cost of Goods Sold, Total

998.5

1,365.5

164.9

286.5

379.9

423.1

Gross Profit

-570.3

-1,056.7

1,011.4

1,129.4

2,078.9

2,339.6

Selling General & Admin Expenses, Total

388.2

600.2

990.1

1,278.7

1,505.3

1,604.2

R&D Expenses

—

—

—

—

—

—

—

1,459.2

1,640.5

1,778.6

1,830.6

Amortization of Goodwill and Intangible Assets

—

—

—

1.3

0.8

0.8

0.8

3.5

3.3

Other Operating Expenses, Total

389.6

601

2,450.1

2,919.9

3,287.4

3,438.2

Operating Income

-959.9

-1,657.7

-1,438.7

-1,790.5

-1,208.5

-1,098.6

Interest Expense, Total

-10.3

-18

-28.2

-19.1

-4.2

-3.2

Interest And Investment Income

—

19.4

20

12.5

71.6

78.2

77.3

Net Interest Expenses

9.1

2

-15.8

52.5

74

74.2

Income (Loss) On Equity Invest.

—

—

—

—

—

—

-0.5

-1.8

-3.7

-7.9

-8.6

Other Non Operating Income (Expenses)

7.2

25.5

8.3

-194.3

-39.5

-53.1

EBT, Excl. Unusual Items

-943.6

-1,630.7

-1,448

-1,936

-1,181.9

-1,086.2

Gain (Loss) On Sale Of Investments

—

—

—

—

12.5

9.4

-25

-6.9

-9.1

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

—

—

Other Unusual Items

—

—

—

—

—

—

—

—

362.9

362.9

EBT, Incl. Unusual Items

-943.6

-1,618.2

-1,438.6

-1,961

-825.8

-732.3

Income Tax Expense

—

—

7

10.4

19.2

42.8

55.9

52.1

Earnings From Continuing Operations

-950.6

-1,628.6

-1,457.8

-2,003.8

-881.7

-784.4

Minority Interest

—

—

2

3.6

—

—

—

—

Net Income

-948.6

-1,625

-1,457.8

-2,003.8

-881.7

-784.4

Net Income to Common Incl Extra Items

-948.6

-1,625

-1,457.8

-2,003.8

-881.7

-784.4

Net Income to Common Excl. Extra Items

-948.6

-1,625

-1,457.8

-2,003.8

-881.7

-784.4

Total Shares Outstanding

61.6

91.6

102.7

104.3

104.6

104.6

Weighted Avg. Shares Outstanding

60.1

83.5

92.8

103.1

104.4

104.4

Weighted Avg. Shares Outstanding Dil

60.1

83.5

92.8

103.1

104.4

104.4

EPS

-15.8

-19.5

-15.7

-19.4

-8.4

-7.5

EPS Diluted

-15.8

-19.5

-15.7

-19.4

-8.4

-7.5

EBITDA

-941.3

-1,625.9

-1,393.2

-1,727.4

-1,124.6

-1,009.8

Effective Tax Rate

—

—

-0.7%

-0.6%

-1.3%

-2.2%

-6.8%

-7.1%